Barclays's 'Bang-for-the-buck' Tail Hedging ETFs: HYG, XLF, IYR
Biotech ETF (XBI) Ended a Diagonal: Looking for Buying Dips
SPDR S&P Biotech ETF Options Spot-On: On November 22nd, 111.5K Contracts Were Traded, With 938.42K Open Interest
On November 22nd ET, $SPDR S&P Biotech ETF(XBI.US)$ had active options trading, with a total trading volume of 111.5K options for the day, of which put options accounted for 34.48% of the total
3 'Buy' Stocks and 2 'Hold' Stocks According to Oppenheimer
Health Care Sector Had the Most Stocks With 4-week Low and RSI Below 30 Since Spring
Health Care Saw the Largest Sector Weight in Q4, but the Largest Outflow in Q3